Clinical Trials Logo

Kidney Diseases clinical trials

View clinical trials related to Kidney Diseases.

Filter by:

NCT ID: NCT03220061 Completed - Kidney Diseases Clinical Trials

Effectiveness of Music Therapy on Blood Pressure and Anxiety Among Patients Undergoing Haemodialysis

Start date: December 12, 2016
Phase: N/A
Study type: Interventional

Effectiveness of music therapy on blood pressure and anxiety among patients undergoing haemodialysis

NCT ID: NCT03213158 Completed - Clinical trials for End Stage Renal Disease

Ixazomib for Desensitization

IXADES
Start date: September 15, 2017
Phase: Phase 2
Study type: Interventional

The purpose of this research study is to find out how well ixazomib (the study drug) works to desensitize highly sensitized kidney transplant recipients.

NCT ID: NCT03202914 Completed - Clinical trials for Dietary Modification

Metabolomics for Identifying Biomarkers of Dietary Intake and Kidney Disease Progression

MDRD
Start date: October 1988
Phase: N/A
Study type: Interventional

The present record represents a secondary data analysis of the Modification of Diet in Renal Disease (MDRD) Study. For this analysis, the MDRD study data and specimens were retrieved from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Central Repository. A global, untargeted, metabolomic profile was used to investigate biomarkers of dietary intake as well as biomarkers of kidney disease progression.

NCT ID: NCT03190070 Completed - Kidney Diseases Clinical Trials

Measurement of Renal Functional Reserve

Start date: July 12, 2017
Phase: N/A
Study type: Interventional

Single arm physiological study to measure renal functional reserve as a biomarker of kidney function and health

NCT ID: NCT03189212 Completed - Clinical trials for End Stage Renal Disease

Feasibility Study of Telemedicine for Dialysis Patients Awaiting Transplantation

Start date: October 1, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether a telemedicine follow-up visit at the NYU Langone Transplant Institute is a feasible and acceptable alternative to a traditional in-center follow-up visit.

NCT ID: NCT03152097 Completed - Clinical trials for Cardiovascular Diseases

Targeting FMO-Mediated TMAO Formation in Kidney Disease (TMAO) Study

TMAO
Start date: March 30, 2018
Phase: N/A
Study type: Interventional

The project will investigate the modulation of flavin-containing monooxygenase (FMO) formation of the CVD risk factor trimethylamine-N-oxide (TMAO) in patients with kidney disease.

NCT ID: NCT03149328 Completed - Clinical trials for Kidney Disease, End-Stage

Electronic Patient-Reported Outcomes in Clinical Kidney Practice (ePRO Kidney)

Start date: August 28, 2017
Phase: N/A
Study type: Interventional

People living with end-stage kidney disease (ESKD) need dialysis or transplantation in order to stay alive. This illness and treatment significantly impact peoples' health, emotions, work and relationships. To promote person-centred care, healthcare professionals should be asking patients about what matters to them and using this feedback to plan and deliver care. Patient-reported outcome and experience questionnaires (jointly referred to as PROs) allow patients to provide information about their quality of life, symptoms and experiences with care. PROs are increasingly used to help healthcare professionals learn about what is important to patients and the impacts of illness or treatments from patients' point of view. Embedding feedback from patients into routine clinical practice is important in end-stage kidney disease because of the physical and quality of life challenges these patients face when living with kidney failure. PROs provide vital and often missing information that the healthcare team can use to support patients. However, PROs administered via paper questionnaires have been perceived as cumbersome, difficult to integrate with other health information and do not provide immediate feedback. In this research, home dialysis patients will have the opportunity to complete electronically administered PROs (ePROs) and healthcare professionals will receive education about how to use PRO information. The goal is to learn how to support healthcare professionals to routinely use this information to inform patient care, and see if this makes a difference in patients' symptoms, person-centred care, quality of life and satisfaction with care. Learning what matters most to patients is essential for healthcare professionals to provide person-centred care. This research will address the gap in our understanding of how to best use patients' reports in healthcare. Findings of this research may ultimately improve the quality of healthcare for Canadians living with end-stage kidney disease.

NCT ID: NCT03114852 Completed - Kidney Diseases Clinical Trials

Familiar Renal Disease, Epidemiology and Genetics in Niteroi/Rio de Janeiro

REGENT
Start date: March 20, 2017
Phase:
Study type: Observational

The REGENT study (Familiar Renal Disease, Epidemiology and Genetics in Niteroi/Rio de Janeiro) is a epidemiological study that try to identify and clinically describe questions about genetic renal diseases in a southeast Brazilian population undergoing renal replacement therapy.

NCT ID: NCT03111381 Completed - Pain, Postoperative Clinical Trials

Toradol to Reduce Ureteroscopic Symptoms Trial

TRUST
Start date: August 1, 2017
Phase: Phase 2
Study type: Interventional

Double blinded randomized controlled clinical trial to assess the impact of intraoperative Toradol on post-operative pain scores for patients undergoing ureteroscopy for urinary stone management.

NCT ID: NCT03105271 Completed - Sickle Cell Disease Clinical Trials

Acute Kidney Injury in Patients With Sickle Cell Disease

Start date: January 1, 2017
Phase:
Study type: Observational

Patients with sickle cell disease may be at risk for acute kidney injury (AKI)during sickle cell crisis (pain or acute chest syndrome). This study will evaluate the role of hemolysis during SCD crisis on the development of AKI and the role for monitoring urine biomarkers during an admission for crisis and during well clinic follow-up.